Pages that link to "Q36862511"
Jump to navigation
Jump to search
The following pages link to Breakpoint-specific multiplex polymerase chain reaction allows the detection of IKZF1 intragenic deletions and minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia. (Q36862511):
Displaying 27 items.
- Current concepts in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (Q27025242) (← links)
- Speed of leukemia development and genetic diversity in xenograft models of T cell acute lymphoblastic leukemia (Q30832617) (← links)
- Somatic Mutation Allelic Ratio Test Using ddPCR (SMART-ddPCR): An Accurate Method for Assessment of Preferential Allelic Imbalance in Tumor DNA. (Q35843497) (← links)
- Ikaros6 is associated with BCR-ABL1 and myeloid-associated antigens but indicates poor prognosis independently in Chinese adult B-cell acute lymphoblastic leukemia. (Q35958876) (← links)
- Prognostic impact of IKZF1 deletion in adults with common B-cell acute lymphoblastic leukemia (Q35986474) (← links)
- Function of Ikaros as a tumor suppressor in B cell acute lymphoblastic leukemia (Q36562871) (← links)
- COBL is a novel hotspot for IKZF1 deletions in childhood acute lymphoblastic leukemia (Q37619704) (← links)
- Direct interaction of Ikaros and Foxp1 modulates expression of the G protein-coupled receptor G2A in B-lymphocytes and acute lymphoblastic leukemia. (Q37662338) (← links)
- Minimal residual disease in acute lymphoblastic leukemia: optimal methods and clinical relevance, pitfalls and recent approaches (Q38257363) (← links)
- Ikaros and leukaemia (Q38371003) (← links)
- Ikaros deletions in BCR-ABL-negative childhood acute lymphoblastic leukemia are associated with a distinct gene expression signature but do not result in intrinsic chemoresistance (Q38475422) (← links)
- Refinement of IKZF1 recombination hotspots in pediatric BCP-ALL patients (Q40582741) (← links)
- Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative study. (Q41556401) (← links)
- IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951. (Q41688725) (← links)
- Changing of IKZF1 genotype during Philadelphia-negative precursor-B acute lymphoblastic leukemia progression: a short clinical report (Q41874989) (← links)
- Loss-of-function but not dominant-negative intragenic IKZF1 deletions are associated with an adverse prognosis in adult BCR-ABL-negative acute lymphoblastic leukemia (Q42368324) (← links)
- Impact of IKZF1 deletions on IKZF1 expression and outcome in Philadelphia chromosome negative childhood BCP-ALL. Reply to "incidence and biological significance of IKZF1/Ikaros gene deletions in pediatric Philadelphia chromosome negative and Philade (Q42831329) (← links)
- Successful tyrosine kinase inhibitor therapy in a refractory B-cell precursor acute lymphoblastic leukemia with EBF1-PDGFRB fusion (Q42924716) (← links)
- An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions. (Q43922213) (← links)
- ETV6-ABL1 fusion combined with monosomy 7 in childhood B-precursor acute lymphoblastic leukemia (Q47572863) (← links)
- An update on PCR use for minimal residual disease monitoring in acute lymphoblastic leukemia (Q47955491) (← links)
- Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols. (Q53831155) (← links)
- Acute lymphoblastic leukemia (Q58481759) (← links)
- Cooperative genetic changes in pediatric B-cell precursor acute lymphoblastic leukemia with deletions or mutations ofIKZF1 (Q59529214) (← links)
- Initial Diagnostic Work-Up of Acute Leukemia: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists and American Society of Hematology Guideline. (Q64937012) (← links)
- Prognostic impact of IKZF1 deletions in association with vincristine-dexamethasone pulses during maintenance treatment of childhood acute lymphoblastic leukemia on trial ALL-BFM 95 (Q88117262) (← links)
- IKZF1 deletions in pediatric acute lymphoblastic leukemia: still a poor prognostic marker? (Q91843913) (← links)